Growing community of inventors

Penzberg, Germany

Kirsten Sonn

Average Co-Inventor Count = 6.86

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 34

Kirsten SonnBernhard Suppmann (2 patents)Kirsten SonnRainer Mueller (1 patent)Kirsten SonnHarald Sobek (1 patent)Kirsten SonnJohann-Peter Thalhofer (1 patent)Kirsten SonnManfred Schmidt (1 patent)Kirsten SonnWerner Hoelke (1 patent)Kirsten SonnManfred Schmidt (1 patent)Kirsten SonnBernd Schneidinger (1 patent)Kirsten SonnMarkus Pajatsch (1 patent)Kirsten SonnIngo Curdt (1 patent)Kirsten SonnArtur Hoffmann (1 patent)Kirsten SonnThomas Marx (1 patent)Kirsten SonnIngo Curdt (1 patent)Kirsten SonnArtur Hoffmann (1 patent)Kirsten SonnHoelke Werner (1 patent)Kirsten SonnThomas Marx (1 patent)Kirsten SonnMarkus Pajatsch (1 patent)Kirsten SonnKirsten Sonn (2 patents)Bernhard SuppmannBernhard Suppmann (7 patents)Rainer MuellerRainer Mueller (24 patents)Harald SobekHarald Sobek (24 patents)Johann-Peter ThalhoferJohann-Peter Thalhofer (19 patents)Manfred SchmidtManfred Schmidt (3 patents)Werner HoelkeWerner Hoelke (13 patents)Manfred SchmidtManfred Schmidt (7 patents)Bernd SchneidingerBernd Schneidinger (5 patents)Markus PajatschMarkus Pajatsch (2 patents)Ingo CurdtIngo Curdt (2 patents)Artur HoffmannArtur Hoffmann (1 patent)Thomas MarxThomas Marx (1 patent)Ingo CurdtIngo Curdt (1 patent)Artur HoffmannArtur Hoffmann (1 patent)Hoelke WernerHoelke Werner (1 patent)Thomas MarxThomas Marx (1 patent)Markus PajatschMarkus Pajatsch (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Roche Diagnostics Operations, Inc. (2 from 1,648 patents)

2. Roche Diagnostics Gmbh (480 patents)

3. F. Hoffmann-la Roche Ag (168 patents)


2 patents:

1. 8236356 - [object Object]

2. 7494797 - Recombinant terminal deoxynucleotidyl transferase with improved functionality

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/3/2025
Loading…